RISPERIDONE ZENTIVA 4 mg, film-coated tablet scored 30 tablets, CIP 3400937760430
Active ingredients: Risperidone
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored30 tablets, CIP 3400937760430orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RISPERIDONE ZENTIVA 4 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 16 Nov 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60812134CIP73776043CIP133400937760430Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISPÉRIDONEcomprimé | 4,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.